Cantel Medical (CMD) Tops Q4 EPS by 1c

Cantel Medical (NYSE: CMD) reported Q4 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $228.9 million versus the consensus estimate of $225.98 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c